EB-101 Surgical application of RDEB wounds
EB-101-CL-302
Phase 3 mab active
Quick answer
EB-101 Surgical application of RDEB wounds for Epidermolysis Bullosa is a Phase 3 program (mab) at ABEONA THERAPEUTICS INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ABEONA THERAPEUTICS INC.
- Indication
- Epidermolysis Bullosa
- Phase
- Phase 3
- Modality
- mab
- Status
- active